Actualités/Reuters/Curevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechCurevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechRefinitivMoins d'1 minute de lectureCVACGSKPFEBNTXCurevac CVAC said on Thursday that the company and GSK GSK have entered an agreement to resolve patent dispute with Pfizer PFE and BioNTech BNTX over mRNA-based COVID-19 vaccines. Actions allemandesActions américainesActions britanniquesEuropeReutersÉtats financiers© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.htmlMontrer plusConnectez-vous ou créez un compte gratuit à vie pour lire ces nouvellesC'est parti
